S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
All the trading advice you’ve ever received boils down to this (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
All the trading advice you’ve ever received boils down to this (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
All the trading advice you’ve ever received boils down to this (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
All the trading advice you’ve ever received boils down to this (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
All the trading advice you’ve ever received boils down to this (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
All the trading advice you’ve ever received boils down to this (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
All the trading advice you’ve ever received boils down to this (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
All the trading advice you’ve ever received boils down to this (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Macron booed by French farmers who blame him for not doing enough to support agriculture

Merit Medical Systems (MMSI) Competitors

$79.81
+0.01 (+0.01%)
(As of 02/23/2024 ET)

MMSI vs. HAE, ICUI, GKOS, INSP, IART, AXNX, IRTC, NARI, PRCT, and ATEC

Should you be buying Merit Medical Systems stock or one of its competitors? The main competitors of Merit Medical Systems include Haemonetics (HAE), ICU Medical (ICUI), Glaukos (GKOS), Inspire Medical Systems (INSP), Integra LifeSciences (IART), Axonics (AXNX), iRhythm Technologies (IRTC), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), and Alphatec (ATEC). These companies are all part of the "surgical & medical instruments" industry.

Merit Medical Systems vs.

Haemonetics (NYSE:HAE) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, community ranking, institutional ownership, risk, valuation, analyst recommendations and earnings.

Haemonetics has a beta of 0.34, meaning that its share price is 66% less volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500.

In the previous week, Merit Medical Systems had 3 more articles in the media than Haemonetics. MarketBeat recorded 10 mentions for Merit Medical Systems and 7 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.87 beat Merit Medical Systems' score of 0.44 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Haemonetics
2 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Merit Medical Systems
3 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

99.4% of Haemonetics shares are held by institutional investors. Comparatively, 93.2% of Merit Medical Systems shares are held by institutional investors. 1.8% of Haemonetics shares are held by insiders. Comparatively, 3.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Haemonetics has a net margin of 9.97% compared to Haemonetics' net margin of 8.17%. Merit Medical Systems' return on equity of 22.37% beat Haemonetics' return on equity.

Company Net Margins Return on Equity Return on Assets
Haemonetics9.97% 22.37% 9.71%
Merit Medical Systems 8.17%14.71%9.99%

Merit Medical Systems received 19 more outperform votes than Haemonetics when rated by MarketBeat users. Likewise, 68.44% of users gave Merit Medical Systems an outperform vote while only 61.00% of users gave Haemonetics an outperform vote.

CompanyUnderperformOutperform
HaemoneticsOutperform Votes
380
61.00%
Underperform Votes
243
39.00%
Merit Medical SystemsOutperform Votes
399
68.44%
Underperform Votes
184
31.56%

Haemonetics currently has a consensus price target of $104.67, suggesting a potential upside of 42.38%. Merit Medical Systems has a consensus price target of $91.13, suggesting a potential upside of 14.18%. Given Merit Medical Systems' higher possible upside, equities research analysts plainly believe Haemonetics is more favorable than Merit Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Haemonetics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Merit Medical Systems
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

Haemonetics has higher revenue and earnings than Merit Medical Systems. Haemonetics is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Haemonetics$1.17B3.19$115.40M$2.4629.88
Merit Medical Systems$1.15B4.00$74.52M$1.7346.13

Summary

Merit Medical Systems beats Haemonetics on 11 of the 18 factors compared between the two stocks.


Get Merit Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MMSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MMSI vs. The Competition

MetricMerit Medical SystemsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$4.61B$3.97B$5.19B$7.51B
Dividend YieldN/A2.08%2.85%3.86%
P/E Ratio46.1319.71227.3317.86
Price / Sales4.0043.913,356.57210.94
Price / Cash18.2831.7899.3855.40
Price / Book3.974.084.394.60
Net Income$74.52M$20.59M$115.26M$207.21M
7 Day Performance0.45%-1.82%0.90%-1.07%
1 Month Performance-0.09%10.58%7.28%3.57%
1 Year Performance12.95%3.62%10.69%5.52%

Merit Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HAE
Haemonetics
4.4572 of 5 stars
$71.41
-1.3%
$104.67
+46.6%
-8.6%$3.67B$1.27B29.033,034Gap Down
ICUI
ICU Medical
3.3606 of 5 stars
$105.19
-1.3%
$122.00
+16.0%
-41.8%$2.54B$2.28B-89.9114,500Upcoming Earnings
GKOS
Glaukos
3.6036 of 5 stars
$92.18
-0.5%
$89.50
-2.9%
+83.4%$4.50B$282.86M-34.27783Earnings Report
Analyst Report
Analyst Revision
News Coverage
INSP
Inspire Medical Systems
4.5642 of 5 stars
$191.71
-0.6%
$272.92
+42.4%
-30.1%$5.67B$624.80M-259.071,011Positive News
IART
Integra LifeSciences
3.3723 of 5 stars
$45.20
+0.4%
$46.22
+2.3%
-21.3%$3.53B$1.56B37.363,722Upcoming Earnings
News Coverage
AXNX
Axonics
3.4781 of 5 stars
$67.96
+0.3%
$71.09
+4.6%
+17.6%$3.44B$273.70M-271.84610News Coverage
Positive News
IRTC
iRhythm Technologies
3.1436 of 5 stars
$112.17
-1.8%
$133.13
+18.7%
-2.4%$3.44B$410.92M-32.421,793Analyst Report
News Coverage
NARI
Inari Medical
1.9065 of 5 stars
$58.11
-0.6%
$81.29
+39.9%
+4.0%$3.35B$383.47M-968.501,100Upcoming Earnings
News Coverage
PRCT
PROCEPT BioRobotics
0.7434 of 5 stars
$48.98
-2.0%
$44.00
-10.2%
+31.9%$2.47B$116.39M-21.02428Upcoming Earnings
ATEC
Alphatec
4.0496 of 5 stars
$15.40
-0.8%
$22.63
+46.9%
+4.7%$2.10B$350.87M-10.20705Upcoming Earnings
Insider Selling
News Coverage

Related Companies and Tools

This page (NASDAQ:MMSI) was last updated on 2/24/2024 by MarketBeat.com Staff